BCM
KYNB

BBT Capital Management’s Kyntra Bio KYNB Stock Holding History

BBT Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,516
Closed -$2.68M – 95
2015
Q4 		$2.68M Hold
3,516
– – 0.32% 66
2015
Q3 		$1.93M Hold
3,516
– – 0.18% 99
2015
Q2 		$2.07M Hold
3,516
– – 0.19% 98
2015
Q1 		$2.76M Hold
3,516
– – 0.28% 74
2014
Q4 		$2.4M Buy
+3,516
New +$2.26M 0.2% 103

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBT Capital Management's KYNB Position: Q1 2016 in Review

BBT Capital Management sold out of Kyntra Bio (KYNB) in Q1 2016, closing a stake of 3,516 shares — an estimated $2.68M sold.

BBT Capital Management first reported a position in KYNB in Q4 2014 and held it in 5 quarters. The position peaked at $2.76M in Q1 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q1 2016.

  • BBT Capital Management reported no remaining Kyntra Bio position as of Q1 2016 after selling out during the quarter.
  • BBT Capital Management sold 3,516 Kyntra Bio shares in Q1 2016, an estimated $2.68M.
  • BBT Capital Management first reported a position in Kyntra Bio in Q4 2014 and held it in 5 quarters.
  • BBT Capital Management's Kyntra Bio position peaked at $2.76M in Q1 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2016.

Based on BBT Capital Management's 13F filing for Q1 2016, filed 12 May 2016.